A pill for reversible suppression of periods - a new option

July 26, 2001

Two new types of antiprogestins that can suppress menstruation and could end the monthly misery many women suffer have passed their first tests in animals, scientists report in Europe's leading reproductive medicine journal, Human Reproduction.*

Studies in rhesus macaque monkeys show that that one drug - ZK 137 316 - can, depending on dose, allow ovulation but block menstruation, while the other - ZK 230 211 - blocks both ovulation and menstruation. Of great importance, both the drugs block the effects of oestrogen on the lining of the uterus, thus preventing the potentially dangerous build-up of endometrial cells caused by the action of unopposed oestrogen.

The studies have been carried out in Dr Robert Brenner's laboratory in the Division of Reproductive Sciences at Oregon Regional Primate Research Centre in the USA.

Rhesus macaque monkeys were used because they are one of the only animals that regularly menstruates and the mechanism in the brain, ovary and uterus controlling their periods is identical to that of humans. According to Dr Brenner, senior scientist with the Oregon Center, the results should therefore be directly applicable to women.

He said: "A reliable means of menstrual suppression would greatly improve the quality of life for women. The modern woman is accustomed to having control over her reproductive functions and menstruation is one function that many women would like to control. It is possible to use the oral contraceptive pill without the pill-free interval for this purpose, but not all women can tolerate the Pill and there are some health conditions that proscribe its use.

"Our goal in these studies was to obtain pre-clinical data prior to clinical development, and these results are very encouraging. All the treated animals, regardless of the dose they were given, remained in good health, maintained normal follicular phase concentrations of oestradiol and returned to normal menstrual cycles within 15 to 41 days after treatment stopped."

He said that his laboratory was now working on some of the cellular mechanism underlying the actions of the compounds and collaborating on the next generation of progesterone receptor antagonists with menstruation suppression potential. These compounds have potential tested for suppressing medical conditions such as endometriosis** and uterine fibroids.

Said Dr Brenner: "These new menstrual suppressants are novel in that they use very low doses of progestin antagonists administered for as long as a woman desires to suppress menstruation, and that once the treatment is stopped normal cycles begin again in a very short time. The fact that we have an animal model with a cycle identical to that of a woman has been extremely valuable as it has enabled us quite quickly to develop these potential treatments to the point where they should be available to women within a few years. I would emphasise that we are not talking here only about lifestyle choices but also about the potential to bring relief to the many women who suffer years of misery from distressing complaints such as endometriosis, and painful and excessive monthly bleeding. In fact, excessive bleeding is one of the major reasons that women undergo hysterectomy***, and this treatment may also reduce the need for this surgical procedure, with all its attendant risks and costs."
* Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Human Reproduction. Vol 16. No 8. pp 1562-1574.

** Endometriosis: a difficult-to-treat condition in which clumps of cells that line the uterus escape from the womb and become deposited on other organs in the pelvis, bleeding at the time of periods and causing pain and even infertility in severe cases.

*** Hysterectomy: surgical removal of the uterus


1 PDF version of this press release and full embargoed text of the paper with complete results and participating research teams, can be found from 09.00hrs BST Wednesday 25 July on website: http://www3.oup.co.uk/eshre/press-release/aug201.pdf.

2 Human Reproduction is a monthly journal of the European Society of Human Reproduction and Embryology (ESHRE). Please acknowledge Human Reproduction as a source. ESHRE's website is: http://www.eshre.com

3 Printed texts available on request from Dr Helen Beard, Managing Editor. Tel: 44-0-1954-212404 or email: beardh@humanreproduction.co.uk.

Contact until 27 July:
Margaret Willson (media relations officer)
Tel: 44-0-1536-772181
Fax: 44-0-1536-772191
Mobile: 07973-853347
Home tel: 44-0-1536-770851
Email: m.willson@mwcommunications.org.uk.

Contact from 28 July
Dr Helen Beard (see note 3 for contact details)

European Society of Human Reproduction and Embryology

Related Menstruation Articles from Brightsurf:

Study highlights dual burden of menstruation and homelessness
Homeless New Yorkers who menstruate face numerous challenges due to inadequate access to toilets, bathing spaces, and laundering services, as well as pervasive menstrual stigma.

Higher dementia risk in women with prolonged fertility
Women with a longer reproductive period had an elevated risk for dementia in old age, compared with those who were fertile for a shorter period, a population-based study from the University of Gothenburg shows.

Early menstruation linked to increased menopause symptoms
Early menstruation increases the likelihood of hot flushes and nights sweats decades later at menopause, according to a University of Queensland study.

Physical activity contributes to positive mental well-being in menopausal women
Late menopausal status is associated with an elevated level of depressive symptoms that indicate the negative dimension of mental well-being.

Supporting menstruating girls: Are we making progress?
Attention to menstruation and its relationship to girls' schooling is gaining ground, yet many challenges remain.

Cincinnati researchers say early puberty in girls may be 'big bang theory' for migraine
Adolescent girls who reach puberty at an earlier age may also have a greater chance of developing migraine headaches, according to new research from investigators at the University of Cincinnati (UC) College of Medicine.

Menstrual symptoms linked to nearly 9 days of lost productivity through presenteeism every year
Menstrual period symptoms may be linked to nearly nine days of lost productivity every year through presenteeism, suggests the largest study of its kind, published in the online journal BMJ Open.

Study illustrates gaps in knowledge and lack of support for girls during puberty
A study examined girls' transitions through puberty in Madagascar and ways in which menstruation influences their educational experiences and future sexual and reproductive health.

Policy makers must attend to menstrual stigma to improve wellbeing, study finds
Researchers have found that addressing attitudes to menstruation may be necessary to improve well-being in low and middle-income countries, far more than simply better access to sanitary products.

Study links perimenopause to accelerated fat mass gains, lean mass losses
A UCLA-led study confirms what women approaching menopause have long suspected: menopause does make fat go up.

Read More: Menstruation News and Menstruation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.